Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Shaping the Future: Forum 30, The MPHO Safety and Traceability Summit in Rome


News provided by

ICCBBA

16 Jul, 2024, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Forum 30 Summit

REDLANDS, Calif., July 16, 2024 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authorities for blood Centro Nazionale Sangue ("CNS") and cells/tissues Centro Nazionale Trapianti ("CNT"), will be hosting Forum 30 The MPHO Safety and Traceability Summit on 14-15 November 2024. The Forum 30 Summit is set to provide a transformative experience as it brings together global stakeholders to advance the safety and traceability of Medical Products of Human Origin (MPHO). This pivotal event will take place in the historic city of Rome, Italy.

About the Forum 30 Summit
Theme: The patient in need of MPHO worldwide – achieving and sustaining a global consensus on MPHO safety and traceability.

Purpose:
1. Facilitate a global consensus on advancing MPHO safety and reliability for the patient's benefit.
2. Provide a forum to address healthcare informatics standards, terminology, and coding supporting global MPHO biovigilance and traceability.

Who Will Attend: This invitation-only event aims to bring together a diverse group of stakeholders including patients, clinicians, regulators, and technology experts from around the world. The goal is to foster an inclusive environment where diverse perspectives can be shared, reflecting the global realities and opportunities in MPHO.

Format: The two-day summit will feature engaging plenary and breakout sessions designed to encourage interaction and networking. Attendees will have the opportunity to build meaningful connections and collaborate on advancing patient care and donor well-being.

Program Concept: The program is crafted to encompass various aspects including the patient's perspective, safety, real-life lessons learned, regulatory challenges, future MPHO-based therapies, and the role of technology. Throughout the summit, the importance of robust traceability structures and information standards will be highlighted to address regulatory oversight challenges.

The Forum 30 Summit will build on the pioneering Forum 25 event held in Lisbon in 2019. It promises to be a unique platform for unlocking new perspectives, forging meaningful connections, and charting the course towards improved MPHO safety and traceability worldwide.

"Forum 30 is a unique multi-MPHO event highlighting the common challenges and opportunities in making these products safer. No other conference takes as broad a perspective on transplantation and transfusion safety as Forum 30. ICCBBA, as an international Non-State Actor, is proud to be able to facilitate this meeting of global interest." (Eoin McGrath, Executive Director, ICCBBA)

"The safety and traceability of MPHOs are crucial. Ensuring these products are safe protects patient well-being, while robust traceability systems guarantee the ability to quickly address any potential issues, thereby maintaining trust in healthcare systems and medical treatments. For these and many more reasons it will be an honor to host an event so relevant such as Forum 30 Summit, a great opportunity to confront with patients, clinicians and stakeholders and to strengthen the global health." (Vincenzo De Angelis, Director, CNS)

"The traceability of biological donations has always been a cornerstone of the Italian transplant system. In these terms, our longstanding commitment began in the early 2000s with the creation of a digital system able to track donors and recipients at any time. This traceability is a significant safeguard for citizens and patients, as it ensures transparency. Moreover, Italy has extensive European experience in this field: through the Eurocet 128 service contract, CNT has contributed to implement a single European Coding System. We look forward to welcoming you to Rome for this important meeting." (Giuseppe Feltrin, Managing Director, CNT)

About ICCBBA

ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard. 

The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the Standard. Today it expands as Information Standard for Blood and Transplantation. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.

The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.  ISBT 128 | ICCBBA

About CNS

The Italian national competent authority for blood and blood components acting as coordinator of the national system. Among others, it is responsible for regulatory blood inspectors' qualification through training activities. Homepage - Centro Nazionale Sangue

About CNT

The Italian national competent authority for organs, tissues, cells and MAR coordinating activities from donation to transplantation. Among others, it is responsible for regulatory inspector's qualification through training activities. Trapianti (salute.gov.it)

For the latest updates on the Forum 30 Summit
Subscribe to our ICCBBA newsletter at: https://www.isbt128.org/newsletter  

For More Information
Forum 30 Homepage: Forum 30 2024 (isbt128.org)

Press Contact and other inquires:
Christina Salinas
globaldevelopment@iccbba.org

Photo - https://mma.prnewswire.com/media/2459829/Forum_30_PR_Graphic.jpg

Modal title

Also from this source

Forum 30: Advancing Global Standards for Medical Products of Human Origin

Forum 30: Advancing Global Standards for Medical Products of Human Origin

The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authority for...

ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety

ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety

ICCBBA is proud to announce the recipients of its 2024 Enterprise Grant Awards, recognizing three outstanding organizations that are advancing...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Trade Show News

Trade Show News

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.